Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells

Philip J. Vickers, Michael J. Dufresne, Kenneth H. Cowan

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Multidrug resistance (MDR) in an MCF-7 human breast cancer cell line (MCF7/AdrR) is associated with decreased drug accumulation and overexpression of P-glycoprotein as well as alterations in the levels of specific drug-metabolizing enzymes, including decreased activity of the phase I drug-metabolizing enzyme aryl hydrocarbon hydroxylase (AHH) and increased expression of the anionic form of the phase II drug-metabolizing enzyme glutathione S-transferase. Since the development of MDR in this MCF-7 cell line is also associated with a loss of estrogen receptors (ER), we have examined the expression of cytochrome P450IA1, the gene encoding AHH activity, in other breast cancer cell lines not selected for drug resistance but expressing various levels of ER. These studies show that a relationship exists between 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible AHH activity and the ER content in a series of breast cancer cell lines. In these cell lines expression of AHH activity is regulated, at least in part, at the level of P450IA1 RNA. While TCDD-specific binding proteins (Ah receptors) were found in each of the breast cancer cell lines, there was no apparent relation between the level of nuclear TCDD-binding proteins and the level of TCDD-induc-ible P450IA1 expression. Previous studies from our laboratory have described an inverse relationship between levels of the anionic form of glutathione S-transferase and ER in breast cancer. The findings of the present study suggest that the ER status of breast cancer cells is associated with distinct patterns in the expression of both phase I and phase II drug-metabolizing enzymes, and that these biochemical changes result in differential sensitivities of ER-positive and ER-negative cell lines to the procarcinogen benzo(a)pyrene and the antineoplastic agent ellipticine.

Original languageEnglish (US)
Pages (from-to)157-164
Number of pages8
JournalMolecular Endocrinology
Volume3
Issue number1
DOIs
StatePublished - Jan 1989

Fingerprint

Cytochromes
Estrogen Receptors
Aryl Hydrocarbon Hydroxylases
Breast Neoplasms
Cell Line
Pharmaceutical Preparations
ellipticine
Multiple Drug Resistance
Enzymes
Glutathione Transferase
Carrier Proteins
Benzo(a)pyrene
MCF-7 Cells
P-Glycoprotein
Drug Resistance
Antineoplastic Agents
RNA
Polychlorinated Dibenzodioxins
Genes

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells. / Vickers, Philip J.; Dufresne, Michael J.; Cowan, Kenneth H.

In: Molecular Endocrinology, Vol. 3, No. 1, 01.1989, p. 157-164.

Research output: Contribution to journalArticle

@article{1799c6257b404c9891ee8f936896025a,
title = "Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells",
abstract = "Multidrug resistance (MDR) in an MCF-7 human breast cancer cell line (MCF7/AdrR) is associated with decreased drug accumulation and overexpression of P-glycoprotein as well as alterations in the levels of specific drug-metabolizing enzymes, including decreased activity of the phase I drug-metabolizing enzyme aryl hydrocarbon hydroxylase (AHH) and increased expression of the anionic form of the phase II drug-metabolizing enzyme glutathione S-transferase. Since the development of MDR in this MCF-7 cell line is also associated with a loss of estrogen receptors (ER), we have examined the expression of cytochrome P450IA1, the gene encoding AHH activity, in other breast cancer cell lines not selected for drug resistance but expressing various levels of ER. These studies show that a relationship exists between 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible AHH activity and the ER content in a series of breast cancer cell lines. In these cell lines expression of AHH activity is regulated, at least in part, at the level of P450IA1 RNA. While TCDD-specific binding proteins (Ah receptors) were found in each of the breast cancer cell lines, there was no apparent relation between the level of nuclear TCDD-binding proteins and the level of TCDD-induc-ible P450IA1 expression. Previous studies from our laboratory have described an inverse relationship between levels of the anionic form of glutathione S-transferase and ER in breast cancer. The findings of the present study suggest that the ER status of breast cancer cells is associated with distinct patterns in the expression of both phase I and phase II drug-metabolizing enzymes, and that these biochemical changes result in differential sensitivities of ER-positive and ER-negative cell lines to the procarcinogen benzo(a)pyrene and the antineoplastic agent ellipticine.",
author = "Vickers, {Philip J.} and Dufresne, {Michael J.} and Cowan, {Kenneth H.}",
year = "1989",
month = "1",
doi = "10.1210/mend-3-1-157",
language = "English (US)",
volume = "3",
pages = "157--164",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells

AU - Vickers, Philip J.

AU - Dufresne, Michael J.

AU - Cowan, Kenneth H.

PY - 1989/1

Y1 - 1989/1

N2 - Multidrug resistance (MDR) in an MCF-7 human breast cancer cell line (MCF7/AdrR) is associated with decreased drug accumulation and overexpression of P-glycoprotein as well as alterations in the levels of specific drug-metabolizing enzymes, including decreased activity of the phase I drug-metabolizing enzyme aryl hydrocarbon hydroxylase (AHH) and increased expression of the anionic form of the phase II drug-metabolizing enzyme glutathione S-transferase. Since the development of MDR in this MCF-7 cell line is also associated with a loss of estrogen receptors (ER), we have examined the expression of cytochrome P450IA1, the gene encoding AHH activity, in other breast cancer cell lines not selected for drug resistance but expressing various levels of ER. These studies show that a relationship exists between 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible AHH activity and the ER content in a series of breast cancer cell lines. In these cell lines expression of AHH activity is regulated, at least in part, at the level of P450IA1 RNA. While TCDD-specific binding proteins (Ah receptors) were found in each of the breast cancer cell lines, there was no apparent relation between the level of nuclear TCDD-binding proteins and the level of TCDD-induc-ible P450IA1 expression. Previous studies from our laboratory have described an inverse relationship between levels of the anionic form of glutathione S-transferase and ER in breast cancer. The findings of the present study suggest that the ER status of breast cancer cells is associated with distinct patterns in the expression of both phase I and phase II drug-metabolizing enzymes, and that these biochemical changes result in differential sensitivities of ER-positive and ER-negative cell lines to the procarcinogen benzo(a)pyrene and the antineoplastic agent ellipticine.

AB - Multidrug resistance (MDR) in an MCF-7 human breast cancer cell line (MCF7/AdrR) is associated with decreased drug accumulation and overexpression of P-glycoprotein as well as alterations in the levels of specific drug-metabolizing enzymes, including decreased activity of the phase I drug-metabolizing enzyme aryl hydrocarbon hydroxylase (AHH) and increased expression of the anionic form of the phase II drug-metabolizing enzyme glutathione S-transferase. Since the development of MDR in this MCF-7 cell line is also associated with a loss of estrogen receptors (ER), we have examined the expression of cytochrome P450IA1, the gene encoding AHH activity, in other breast cancer cell lines not selected for drug resistance but expressing various levels of ER. These studies show that a relationship exists between 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible AHH activity and the ER content in a series of breast cancer cell lines. In these cell lines expression of AHH activity is regulated, at least in part, at the level of P450IA1 RNA. While TCDD-specific binding proteins (Ah receptors) were found in each of the breast cancer cell lines, there was no apparent relation between the level of nuclear TCDD-binding proteins and the level of TCDD-induc-ible P450IA1 expression. Previous studies from our laboratory have described an inverse relationship between levels of the anionic form of glutathione S-transferase and ER in breast cancer. The findings of the present study suggest that the ER status of breast cancer cells is associated with distinct patterns in the expression of both phase I and phase II drug-metabolizing enzymes, and that these biochemical changes result in differential sensitivities of ER-positive and ER-negative cell lines to the procarcinogen benzo(a)pyrene and the antineoplastic agent ellipticine.

UR - http://www.scopus.com/inward/record.url?scp=0024532233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024532233&partnerID=8YFLogxK

U2 - 10.1210/mend-3-1-157

DO - 10.1210/mend-3-1-157

M3 - Article

C2 - 2464754

AN - SCOPUS:0024532233

VL - 3

SP - 157

EP - 164

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 1

ER -